Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Nov;26(11):6104-6106.
doi: 10.1038/s41380-021-01167-1. Epub 2021 May 18.

Unraveling the opioid actions of S-ketamine and R-ketamine: comment on Bonaventura et al

Boris D Heifets  1   2 , Brandon S Bentzley  2 , Nolan Williams  2 , Alan F Schatzberg  3
Affiliations
Editorial

Unraveling the opioid actions of S-ketamine and R-ketamine: comment on Bonaventura et al

Boris D Heifets et al. Mol Psychiatry. 2021 Nov.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Zarate CA, Singh JB, Quiroz JA, De Jesus G, Denicoff KK, Luckenbaugh DA, et al. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry. 2016;163:153–5. - DOI
    1. Heresco-Levy U, Javitt DC, Gelfin Y, Gorelik E, Bar M, Blanaru M, et al. Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder. J Affect Disord. 2016;93:239–43. - DOI
    1. Paterson B, Fraser H, Wang C, Marcus R. A randomized, double-blind, placebo-controlled, sequential parallel study of CERC-301 in the adjunctive treatment of subjects with severe depression and recent active suicidal ideation despite antidepressant treatment. Poster presentation at the 2015 National Network of Depression Centers Annual Conference, Nov 5–6, 2015, Ann Arbor, MI, USA.
    1. Sanacora G, Johnson MR, Khan A, Atkinson SD, Riesenberg RR, Schronen JP, et al. Adjunctive lanicemine (AZD6765) in patients with major depressive disorder and history of inadequate response to antidepressants: A randomized, placebo-controlled study. Neuropsychopharmacology. 2017;42:844–53. - DOI
    1. Williams NR, Heifets BD, Blasey C, Sudheimer K, Pannu J, Pankow H, et al. Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am J Psychiatry. 2018;175:1205–15. - DOI

MeSH terms

LinkOut - more resources